Symbols / GRML Stock $0.44 +2.86% Greenland Mines Ltd

Basic Materials • Other Precious Metals & Mining • United States • NCM
GRML (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Basic Materials
Industry Other Precious Metals & Mining
CEO Dr. Joseph A. Sinkule Pharm.D.
Exch · Country NCM · United States
Market Cap 53.62M
Enterprise Value 44.96M
Income -10.55M
Sales
FCF (ttm) -5.30M
Book/sh 0.13
Cash/sh 0.06
Employees 5
Insider 10d
IPO Apr 29, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout
P/E
Forward P/E
PEG
P/S
P/B 3.40
P/C
EV/EBITDA
EV/Sales
Quick Ratio 93.49
Current Ratio 95.01
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA -74.13%
ROE -198.17%
ROIC
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 121.24M
Shs Float 104.55M
Insider Own 17.18%
Instit Own 4.29%
Short Float 6.40%
Short Ratio 1.87
Short Interest 6.53M
52W High 3.91
vs 52W High -88.69%
52W Low 0.12
vs 52W Low 284.61%
Beta 2.62
Impl. Vol.
Rel Volume 0.20
Avg Volume 4.73M
Volume 969.04K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.43
Price $0.44
Change 2.86%
About

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.44
Low
High
Mean
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-04 MCGARITY JON W Director 350,000 $0.00 $0
2026-03-04 ZENTMAN SAMUEL M Director 350,000 $0.00 $0
2026-03-04 HIRSCHMAN SHALOM Z Director 350,000 $0.00 $0
2026-03-04 SINKULE JOSEPH Chief Executive Officer 2,500,000 $0.00 $0
2026-03-04 LEBLANC JEFF Chief Financial Officer 2,500,000 $0.00 $0
2026-03-04 EL-DADA RIAD HUSSEIN Director 350,000 $0.00 $0
2025-08-25 LEBLANC JEFF Chief Financial Officer 200,000 $0.00 $0
2025-08-05 MCGARITY JON W Director 14,641 $0.00 $0
2025-08-05 ZENTMAN SAMUEL M Director 153,494 $0.00 $0
2025-08-05 HIRSCHMAN SHALOM Z Director 70,149 $0.00 $0
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category